(Q73562590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

H Senturk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

O Uzunalimoglu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Y Batur

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

I Simsek

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Mert

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Ozbay

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Cetinkaya

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

G Ersoz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

F Tabak

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Akbaylar

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

M Akdogan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Dokmeci

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

S Ozenirler

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Erden

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

N Tozum

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

Digestive Diseases and Sciences

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

1438-1444

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9246043%20AND%20SRC:MED&resulttype=core&format=json

Improvement of liver fibrosis in chronic hepatitis C patients treated with natural interferon alpha

5 November 2019

cites work

1 reference

12 December 2020

Clinical outcomes after transfusion-associated hepatitis C.

1 reference

12 December 2020

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

12 December 2020

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

1 reference

12 December 2020

Long-term histologic and viral changes in patients with chronic hepatitis C who responded to alpha interferon.

1 reference

12 December 2020

The Significance of Blood Transfusion in Non-A, Non-B Chronic Liver Disease in Japan

1 reference

12 December 2020

Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients

1 reference

12 December 2020

Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes.

1 reference

12 December 2020

Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

A controlled study to determine the optimal dose regimen of interferon-alpha 2b in chronic hepatitis C

1 reference

12 December 2020

Decrease in Serum Hepatitis C Viral RNA during Alpha-Interferon Therapy for Chronic Hepatitis C

1 reference

12 December 2020

The effect of ursodeoxycholic acid on serum enzymes and liver histology in patients with chronic active hepatitis. A 12-month double-blind, placebo-controlled trial

1 reference

12 December 2020

Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study

1 reference

12 December 2020

Effect of ursodeoxycholic acid on HCV replication in subtyped chronic hepatitis C.

1 reference

12 December 2020

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

1 reference

12 December 2020

Ursodiol in the long-term treatment of chronic hepatitis: a double-blind multicenter clinical trial

1 reference

12 December 2020

The breakthrough phenomenon during alpha-interferon therapy of chronic hepatitis C: incidence, management, and outcome.

1 reference

12 December 2020

High-dose interferon-alpha 2b for re-treatment of nonresponders or relapsing patients with chronic hepatitis C. A controlled randomized trial

1 reference

12 December 2020

Discrepancy between biochemical and virological responses to interferon-alpha in chronic hepatitis C.

1 reference

12 December 2020

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients

1 reference

12 December 2020

Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: prevalence, etiology, and management

1 reference

12 December 2020

Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up

1 reference

12 December 2020

Long-term mortality after transfusion-associated non-A, non-B hepatitis. The National Heart, Lung, and Blood Institute Study Group

1 reference

12 December 2020

Recombinant human alpha-interferon in patients with chronic non-A, non-B hepatitis: a multicenter randomized controlled trial from France

1 reference

12 December 2020

Randomized trial comparing three different regimens of alpha-2a-interferon in chronic hepatitis C. The TriVeneto Viral Hepatitis Group

1 reference

12 December 2020

Persistent hepatitis C viremia predicts late relapse after sustained response to interferon-alpha in chronic hepatitis C. TriVeneto Viral Hepatitis Group

1 reference

12 December 2020

High dose interferon alpha-2b therapy for chronic hepatitis C: an open label study of the response and predictors of response

1 reference

12 December 2020

Serum hepatitis C virus RNA quantity and histological features of hepatitis C virus carriers with persistently normal ALT levels

1 reference

12 December 2020

Does the healthy hepatitis C virus carrier state really exist? an analysis using polymerase chain reaction

1 reference

12 December 2020

Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis

1 reference

12 December 2020

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

12 December 2020

High Rate of Infectivity and Liver Disease in Blood Donors with Antibodies to Hepatitis C Virus

1 reference

12 December 2020

The effect of interferon alfa and ribavirin combination therapy in naive patients with chronic hepatitis C.

1 reference

12 December 2020

Natural course of chronic hepatitis C

1 reference

12 December 2020

Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat.

1 reference

12 December 2020

Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources

1 reference

12 December 2020

The virological and histological states of anti-hepatitis C virus-positive subjects with normal liver biochemical values

1 reference

12 December 2020

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

1 reference

12 December 2020